Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Rang in Aktien #28308
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Aktienkurs
$1.11
Marktkapitalisierung
$27.17M
Veränderung (1 Tag)
0.19%
Veränderung (1 Jahr)
58.22%
Land
KR
Handel Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategorie

Operative Marge für Dong Sung Bio Pharm.Co.,Ltd. (002210)
Operative Marge zum August 2026 TTM: -11.02%
Laut den neuesten Finanzberichten und dem Aktienkurs von Dong Sung Bio Pharm.Co.,Ltd. beträgt die aktuelle operative Marge (TTM) -11.02%. Am Ende des Jahres 2023 lag die operative Marge bei 0.67%.
Historie der operativen Marge von Dong Sung Bio Pharm.Co.,Ltd. von 2007 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -11.02% 47.92%
2024 -7.45% -1,211.94%
2023 0.67% -130.59%
2022 -2.19% -65.13%
2021 -6.28% 50.24%
2020 -4.18% -51.95%
2019 -8.70% 341.62%
2018 -1.97% -269.83%
2017 1.16% -140.42%
2016 -2.87% -279.38%
2015 1.60% -164.00%
2014 -2.50% -4.58%
2013 -2.62% -168.05%
2012 3.85% -15.94%
2011 4.58% -204.81%
2010 -4.37% -366.46%
2009 1.64% -36.43%
2008 2.58% -5.84%
2007 2.74% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -102.08%
IN
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.